| 000 | 01417 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517085339.0 | ||
| 264 | 0 | _c20161114 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a1471-2474 | ||
| 024 | 7 |
_a10.1186/s12891-016-0988-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoo, Christopher G K M | |
| 245 | 0 | 0 |
_aClopidogrel and hip fractures, is it safe? A systematic review and meta-analysis. _h[electronic resource] |
| 260 |
_bBMC musculoskeletal disorders _cMar 2016 |
||
| 300 |
_a136 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aBlood Loss, Surgical _xprevention & control |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFemoral Neck Fractures _xsurgery |
| 650 | 0 | 4 |
_aFracture Fixation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDella Torre, Paul K | |
| 700 | 1 | _aYolland, Tristan J | |
| 700 | 1 | _aShatwell, Michael A | |
| 773 | 0 |
_tBMC musculoskeletal disorders _gvol. 17 _gp. 136 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12891-016-0988-9 _zAvailable from publisher's website |
| 999 |
_c25855263 _d25855263 |
||